Floatz logo

Therapeutic Asset Ratings

13,248 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Sra-333
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of PfizerP1B (62)
acd856
Cognition Disorder
AlzeCure PharmaP1B (60)
Itraconazole
Medical Oncology
Boehringer IngelheimP1B (60)
Naltrexone
How Opioid Tone Was Related to Self Reported
Inventage Lab., Inc.P1B (57)
TEONANACATL
Migraine Headache
Yale UniversityP1B (57)
bay2927088
Healthy Volunteers
BayerP1B (56)
cd22 car-transduced t cells
Lymphoma, Non-Hodgkin
Tongji HospitalP1B (56)
Inno-206
Cancer
Centocor, Inc.P1B (56)
Irinotecan
Small Intestine Cancer
University Hospital, GhentP1B (56)
[14c] lpm3770164
Tardive Dyskinesia
Luye Pharma Group Ltd.P1CCC (55)
Carboplatin
Adult Solid Neoplasm
National Cancer Institute (NCI)P1CCC (55)
CIS-DIAMMINEDICHLOROPLATINUM II
Solid Neoplasm
Emory UniversityP1CCC (55)
CIS-DIAMMINEDICHLOROPLATINUM II
Stage IB Cervical Cancer
National Cancer Institute (NCI)P1CCC (55)
Docetaxel
Carcinoma, Non-Small-Cell Lung
Boehringer IngelheimP1CCC (55)
Epigallocatechin-3-Gallate
Idiopathic Pulmonary Fibrosis
Hal ChapmanP1CCC (55)
Inno-206
Myelodysplastic/Myeloproliferative Diseases
Prelude TherapeuticsP1CCC (55)
Irinotecan
Ovarian Clear Cell Cystadenocarcinoma
National Cancer Institute (NCI)P1CCC (55)
Irinotecan
Ovarian Serous Cystadenocarcinoma
National Cancer Institute (NCI)P1CCC (55)
Itraconazole
Relapsed or Refractory Lymphoma
HutchmedP1CCC (55)
Metformin
Sickle Cell Anemia
PfizerP1CCC (55)
PROPRANOLOL
Epithelial Ovarian Cancer
Memorial Sloan Kettering Cancer CenterP1CCC (55)
Rapamycin
Recurrent Breast Carcinoma
Fudan UniversityP1CCC (55)
(+)-VINCRISTINE
Ovarian Clear Cell Cystadenocarcinoma
National Cancer Institute (NCI)P1CCC (55)
(+)-VINCRISTINE
Ovarian Serous Cystadenocarcinoma
National Cancer Institute (NCI)P1CCC (55)
Irinotecan
Refractory Solid Tumors
M.D. Anderson Cancer CenterP1CCC (54)
Showing 1 to 25 of 13,248 assets
PreviousPage 1 of 530Next